These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
7. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Bezchlibnyk-Butler KZ; Remington GJ Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605 [TBL] [Abstract][Full Text] [Related]
12. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
13. Treating extrapyramidal reactions: some current issues. Gelenberg AJ J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced movement disorders. Gershanik OS Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509 [TBL] [Abstract][Full Text] [Related]
16. Biochemical mechanisms and management of choreiform movement disorders. de Silva L Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049 [No Abstract] [Full Text] [Related]
17. Pathophysiology of antipsychotic drug-induced movement disorders. Casey DE J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109 [TBL] [Abstract][Full Text] [Related]